Review Article
Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
Table 1
Circulating sLOX-1 levels in acute coronary syndrome.
| Disease condition | Median (range); P values | Reference |
| ACS Non-ACS | 2.91 (<0.5–170) ng/mL; versus all groups Intact coronary <0.5 (<0.5–1.3) ng/mL Controlled CHD <0.5 (<0.5–3.4) ng/mL Ischemic CHD 0.73 (<0.5–14.0) ng/mL | [13] |
| ACS Stable CAD ACS | 1.61 (0.941–2.264) ng/mL; versus stable CAD 0.579 (0.265–1.172) ng/mL No complex lesion: 1.003 (0.783–1.668) ng/mL One-complex lesion: 1.456 (0.923–2.124) ng/mL Multicomplex lesion: 2.171 (1.067–3.247) ng/mL | [14] |
| ACS + PCI | Re-ACS: 6.60 ng/mL; Event-free: 2.54 ng/mL | [16] |
| ACS with plaque rupture ACS w/o plaque rupture SAP | versus ACS w/o plaque rupture and SAP versus SAP | [17] |
| ACS Non-ACS | 1.13 ng/mL; 0.096 ng/mL | [18] |
| STEMI NSTEMI Non-AMI | 241.0 pg/mL; versus NSTEMI; versus non-AMI 147.3 pg/mL; versus non-AMI 64.3 pg/mL | [19] |
| AAD NSTEACS Control | versus NSTEACS; versus control versus control | [23] |
|
|
ACS: acute coronary syndrome; CAD: coronary artery disease; PCI: percutaneous coronary intervention; SAP: stable angina pectoris; STEMI: ST elevation myocardial infarction; NSTEMI: non-ST elevation myocardial infarction; AMI: acute myocardial infarction; AAD: acute aortic dissection; NSTEACS: non-ST elevation acute coronary syndrome.
|